KINGSTON, R.I. ‚ Oct. 4, 2021 — The University of Rhode Island College of Pharmacy will present its Heber W. Youngken, Jr. Pharmacy Clinic on Nov. 4, offering pharmacists and pharmacy technicians one last chance to secure valuable continuing education credits before the end of the year.
The 64th annual edition of the conference hosted by the URI Office of Continuing Professional Development will be presented as a hybrid in-person and virtual event. The program runs from 8:15 a.m. to 3 p.m. on Thursday, Nov. 4 at the Radisson Airport Hotel, 2081 Post Road, Warwick. It will also be presented virtually via Zoom. Attendees will receive an emailed link to the Zoom meeting upon registering for the conference. For more information and to register, visit uri.edu/pharmce.
In addition to insightful discussions and lectures on some of the key pharmaceutical issues facing the profession today — including the top challenges in fighting COVID-19 in Rhode Island, updates in pandemic treatment and prevention, a controversial new medication to treat Alzheimer’s Disease, and more — the program will offer five live contact hours of continuing pharmacy education credit.
Presenters include some of the leading local voices in the pharmaceutical sciences industry, including URI College of Pharmacy professors; pharmacy and medical experts from Massachusetts General Hospital, Harvard Medical School, Women & Infants Hospital, and more; and officials from the state Department of Health. Featured speakers include Dr. Philip Chan, Brown University professor and medical director with the state Department of Health; Catherine Li, co-director of antimicrobial stewardship at Women & Infants; and Dr. Amanda Baker, Harvard professor and clinical director of the Center for Anxiety and Traumatic Stress Disorders at Massachusetts General Hospital, among others. URI College of Pharmacy Dean Paul Larrat will present annual scholarships awarded to current URI pharmacy students.
The clinic is geared toward both pharmacists and pharmacy techs. Learning objectives for attendees include:
- Discuss the epidemiology of the COVID-19 pandemic in Rhode Island.
- Identify effective COVID-19 mitigation approaches.
- Review challenges associated with addressing the COVID-19 pandemic.
- Develop a treatment plan for outpatient management of coronavirus disease 2019 (COVID-19).
- Develop a treatment plan for inpatient management of coronavirus disease 2019 (COVID-19).
- Evaluate strategies including vaccination for the prevention of COVID-19 transmission and severe disease.
- Describe the current problem of increased anxiety worldwide including more than a 10 percent increase in anxiety and SSRI prescriptions and increasing waitlists for treatment.
- Discuss COVID-specific related anxiety through a Cognitive Behavioral Therapy model.
- Differentiate between anxiety and anxiety disorders.
- Review best practice treatment guidelines.
- Explain specific tools pharmacists can use to help their patients and themselves with challenging anxiety.
- Identify future/novel research directions for addressing anxiety.